SpAlka 2mg 25s Tablets


Tablets per bottle:25, Manufacturer: SP Accure Labs


Composition Melphalan (2mg)
Substituent Alkeran 2mg 25s, Alphalan 2mg 25s
Shipping Room Temperature

Medicine Overview of SpAlka 2mg Tablet


Uses of SpAlka 2mg Tablet

SpAlka 2mg Tablet is used in the treatment of multiple myeloma.

SpAlka 2mg Tablet side effects


Nausea, Vomiting, Stomatitis (Inflammation of the mouth), Anemia (low number of red blood cells), Hair loss, Low blood platelets, Diarrhoea, Decreased white blood cell count.

How to use SpAlka 2mg Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. SpAlka 2mg Tablet is to be taken empty stomach.

How SpAlka 2mg Tablet works

SpAlka 2mg Tablet is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.

In Depth Information on SpAlka 2mg Tablet

Expert advice for SpAlka 2mg Tablet

  • Melphalan to be taken on an empty stomach 1 hour before or 2 hours after meals. Drink at least two to three quarts of fluid every 24 hours, unless you are instructed otherwise.
  • You may be at risk of infection so try to avoid contact with people with cold, fever or any other signs of infection.?
  • Avoid exposure to sunlight. Use sunscreen lotion and protective clothing.?
  • You may be monitored periodically for complete blood counts (at least one determination prior to each treatment course) during the course of treatment.
  • Melphalan may increase the risk that you will develop other cancers. Talk with your doctor about the risks of taking melphalan.
  • Do not take live vaccines if you are an immunocompromised patient.
  • Use of melphalan is not recommended in children.
  • Use with melphalan extreme caution if your bone marrow reserve have been compromised by prior irradiation or chemotherapy, or if your marrow function is recovering from previous cytotoxic therapy.
  • Use appropriate contraceptive methods to avoid pregnancy during melphalan treatment.

SpAlka 2mg Tablet related warnings

Special precautions for SpAlka 2mg Tablet

Interaction with alcohol is unknown. Please consult your doctor.
SpAlka 2mg Tablet is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
SpAlka 2mg Tablet is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable.
It is not known whether SpAlka 2mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
SpAlka 2mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of SpAlka 2mg Tablet may be needed. Please consult your doctor.
There is limited information available on the use of SpAlka 2mg Tablet in patients with liver disease. Please consult your doctor.

What if you miss a dose of SpAlka 2mg Tablet?

If you miss a dose of SpAlka 2mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Additional information

Weight 0.035 kg